Skip to content
Ultralife logo

Ultralife (ULBI) Q1 2026 Annual Earnings

ULBI·Reported May 8, 2026·Before market open

Ultralife reported Q1 2026 revenue of $47.4M (-6.5% YoY), missed analyst consensus of $52.4M by $5.0M. Diluted EPS came in at $-0.03, missed the $0.15 consensus by $0.18.

Revenue
$47.4Mmissed by $5.0M
Consensus: $52.4M
Diluted EPS
$-0.03missed by $0.18
Consensus: $0.15
SEC

SEC Filings

Financial Snapshot

Trailing eight quarters through Q1 2026

Q1 2026 Earnings FAQ

Common questions about Ultralife's Q1 2026 earnings report.

Ultralife (ULBI) reported Q1 2026 earnings on May 8, 2026 before market open.

Ultralife reported revenue of $47.4M and diluted EPS of $-0.03 for Q1 2026.

Revenue missed the consensus estimate of $52.4M by $5.0M. EPS missed the consensus estimate of $0.15 by $0.18.

Compared to the same quarter a year prior, revenue declined 6.5% from $50.7M a year earlier.

You can read the 8-K earnings release (0001437749-26-015749) and the 10-K/A periodic report (0001437749-26-013737) directly on SEC EDGAR. The filing index links above go to sec.gov.